156 related articles for article (PubMed ID: 826651)
1. Epidermal cell proliferation and promoting ability of phorbol esters.
Slaga TJ; Scribner JD; Viaje A
J Natl Cancer Inst; 1976 Nov; 57(5):1145-9. PubMed ID: 826651
[TBL] [Abstract][Full Text] [Related]
2. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo.
Mufson RA; Fischer SM; Verma AK; Gleason GL; Slaga TJ; Boutwell RK
Cancer Res; 1979 Dec; 39(12):4791-5. PubMed ID: 227591
[TBL] [Abstract][Full Text] [Related]
3. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
Argyris TS
Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
[No Abstract] [Full Text] [Related]
4. Effects of structural changes on the tumor-promoting activity of phorbol myristate acetate on mouse skin.
Van Duuren BL; Tseng SS; Segal A; Smith AC; Melchionne S; Seidman I
Cancer Res; 1979 Jul; 39(7 Pt 1):2644-6. PubMed ID: 109195
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
Slaga TJ; Fischer SM; Nelson K; Gleason GL
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
[TBL] [Abstract][Full Text] [Related]
6. Acetic acid, a potent stimulator of mouse epidermal macromolecular synthesis and hyperplasia but with weak tumor-promoting ability.
Slaga TJ; Bowden GT; Boutwell RK
J Natl Cancer Inst; 1975 Oct; 55(4):983-7. PubMed ID: 1185813
[TBL] [Abstract][Full Text] [Related]
7. Skin tumor promotion by phorbol esters is a two-stage process.
Fürstenberger G; Berry DL; Sorg B; Marks F
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7722-6. PubMed ID: 6801661
[TBL] [Abstract][Full Text] [Related]
8. Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin.
Szallasi Z; Krsmanovic L; Blumberg PM
Cancer Res; 1993 Jun; 53(11):2507-12. PubMed ID: 8495413
[TBL] [Abstract][Full Text] [Related]
9. Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-O-tetra-decanoylphorbol-13-acetate.
Sisskin EE; Gray T; Barrett JC
Carcinogenesis; 1982; 3(4):403-7. PubMed ID: 6807562
[No Abstract] [Full Text] [Related]
10. Suppression of the first stage of phorbol 12-tetradecanoate 13-acetate-effected tumor promotion in mouse skin by nontoxic inhibition of DNA synthesis.
Kinzel V; Loehrke H; Goerttler K; Fürstenberger G; Marks F
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5858-62. PubMed ID: 6435122
[TBL] [Abstract][Full Text] [Related]
11. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
12. Phorbol as a possible systemic promoting agent for skin carcinogenesis.
Armuth V; Berenblum I
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jan; 85(1):79-82. PubMed ID: 129971
[TBL] [Abstract][Full Text] [Related]
13. Improved tumour yields by means of a TPA-DMBA-TPA variation of the Berenrlum-Mottram experiment on the back skin of NMRI mice. The effect of stationary hyperplasia without inflammation.
Goerttler K; Loehrke H
Exp Pathol (Jena); 1976; 12(6):336-41. PubMed ID: 827451
[TBL] [Abstract][Full Text] [Related]
14. Minimal role of enhanced cell proliferation in skin tumor promotion by mirex: a nonphorbol ester-type promoter.
Meyer SA; Moser GJ; Monteiro-Riviere NA; Smart RC
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):265-9. PubMed ID: 8013418
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
Yokota K; Gill TJ; Shinozuka H
Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents.
DiGiovanni J; Walker SC; Beltran L; Naito M; Eastin WC
Cancer Res; 1991 Mar; 51(5):1398-405. PubMed ID: 1900038
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of mouse skin tumor promotion by chrysarobin.
DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
[TBL] [Abstract][Full Text] [Related]
18. Sapintoxin D is a weak tumour promoter in Sencar mouse skin.
McLean JR; Plant M; Lecuyer DW; Davidson C; Truong J
J Pharm Pharmacol; 1995 Mar; 47(3):263. PubMed ID: 7602494
[No Abstract] [Full Text] [Related]
19. The chlorinated pesticide mirex is a novel nonphorbol ester-type tumor promoter in mouse skin.
Moser GJ; Meyer SA; Smart RC
Cancer Res; 1992 Feb; 52(3):631-6. PubMed ID: 1732051
[TBL] [Abstract][Full Text] [Related]
20. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
